- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Phathom Pharmaceuticals Inc (PHAT)
Assess today's live Phathom Pharmaceuticals Inc (PHAT) share price, performance and insights using our live NASDAQ: PHAT stock exchange data.
Analyse the historical data and Phathom Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Phathom Pharma share price buy/sell indicators using real-time data (or discuss the Phathom Pharma (PHAT) stock price today with other investors in the Phathom Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PHAT share price (ISIN: US71722W1071) to enhance your trading decisions with our free investment tools and resources.
What Is the Phathom Pharmaceuticals Inc Share Price Today?
The Phathom Pharma share price today is 17.25.
What Is the Stock Symbol for Phathom Pharmaceuticals Inc
The stock symbol (or 'ticker') for Phathom Pharmaceuticals Inc is "PHAT."
What Stock Exchange Does Phathom Pharmaceuticals Inc Trade On?
Phathom Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Phathom Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Phathom Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Phathom Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Phathom Pharma share price buy/sell indicators using real-time data (or discuss the Phathom Pharma (PHAT) stock price today with other investors in the Phathom Pharma NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ PHAT share price (ISIN: US71722W1071) to enhance your trading decisions with our free investment tools and resources.
What Is the Phathom Pharmaceuticals Inc Share Price Today?
The Phathom Pharma share price today is 17.25.
What Is the Stock Symbol for Phathom Pharmaceuticals Inc
The stock symbol (or 'ticker') for Phathom Pharmaceuticals Inc is "PHAT."
What Stock Exchange Does Phathom Pharmaceuticals Inc Trade On?
Phathom Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Phathom Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Phathom Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.77
18.31
52 wk Range
2.21
18.31
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.7718.31
52 wk Range
2.2118.31
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHAT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
22.90
Upside
+32.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Phathom Pharma Company Profile
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Phathom Pharmaceuticals Inc Earnings Call Summary for Q3/2025
- Phathom Pharmaceuticals reported Q3 2025 EPS of -$0.15 (beating -$0.47 forecast) and revenue of $49.5M (25% QoQ growth), driving a 15.08% stock surge
- Company achieved 43% reduction in cash operating expenses and 77% reduction in cash usage QoQ, while maintaining an 87% gross profit margin
- Management narrowed full-year revenue guidance to $170-175M and forecasts achieving operating profitability in 2026
- Strategic realignment focuses sales territories exclusively on gastroenterology, with potential primary care expansion planned for 2027-2028
- Current market penetration stands at only 3%, highlighting significant growth opportunity despite continued unprofitability
Last Updated: 30/10/2025, 13:52
Read Full TranscriptCompare PHAT to Peers and Sector
Metrics to compare | PHAT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHATPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | 2.2x | −0.6x | |
PEG Ratio | −0.13 | 0.24 | 0.00 | |
Price/Book | −2.8x | 2.0x | 2.6x | |
Price / LTM Sales | 8.2x | 3.7x | 3.2x | |
Upside (Analyst Target) | 39.1% | 50.7% | 41.8% | |
Fair Value Upside | Unlock | −1.3% | 5.1% | Unlock |
Analyst Ratings
9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.90
(+32.75% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
-0.15 / -0.47
Revenue / Forecast
49.50M / 47.03M
People Also Watch
FAQ
What Is the Phathom Pharma (PHAT) Share Price Today?
The live Phathom Pharma share price today is 17.25
What Stock Exchange Does Phathom Pharma (PHAT) Trade On?
Phathom Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Phathom Pharma?
The stock symbol (also called a 'ticker') for Phathom Pharma is "PHAT."
What Is the Current Phathom Pharma Market Cap?
As of today, Phathom Pharma market capitalisation is 1.20B.
What Is Phathom Pharma's (PHAT) Earnings Per Share (TTM)?
The Phathom Pharma EPS is currently -3.80 (Trailing Twelve Months).
When Is the Next Phathom Pharma Earnings Date?
Phathom Pharma's next earnings report will be released on 03 Mar 2026.
Is PHAT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Phathom Pharma moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Phathom Pharma Stock Split?
Phathom Pharma has split 0 times. (See the PHAT stock split history page for full effective split date and price information.)
How Many Employees Does Phathom Pharma Have?
Phathom Pharma has 427 employees.
What is the current trading status of Phathom Pharma (PHAT)?
As of 24 Dec 2025, Phathom Pharma (PHAT) is trading at a price of 17.25, with a previous close of 17.87. The stock has fluctuated within a day range of 16.77 to 18.31, while its 52-week range spans from 2.21 to 18.31.
What Is Phathom Pharma (PHAT) Price Target According to Analysts?
The average 12-month price target for Phathom Pharma is USD22.9, with a high estimate of USD29 and a low estimate of USD12. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.75% Upside potential.
What Is the PHAT Premarket Price?
PHAT's last pre-market stock price is 17.94. The pre-market share volume is 8,930.00, and the stock has decreased by 0.07, or 0.39%.
What Is the PHAT After Hours Price?
PHAT's last after hours stock price is 17.81, the stock has decreased by 0.56, or 3.25%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.